Literature DB >> 2003972

Cancer cachexia.

M J Tisdale.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2003972      PMCID： PMC1971880          DOI： 10.1038/bjc.1991.80

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  56 in total

Review 1.  A spectrum of tumors that produce paraneoplastic syndromes. Lung tumors: how they produce their syndromes.

Authors:  L Nathanson; T C Hall
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

2.  Cachexia, gluconeogenesis and progressive weight loss in cancer patients.

Authors:  T P Stein
Journal:  J Theor Biol       Date:  1978-07-06       Impact factor: 2.691

Review 3.  Methods for growth of cultured cells in serum-free medium.

Authors:  D Barnes; G Sato
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

4.  Lessons from the study of induced alterations in amino acids in patients with cancer.

Authors:  J F Holland; T Ohnuma
Journal:  Cancer Treat Rep       Date:  1979-06

5.  Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid.

Authors:  M J Tisdale; S A Beck
Journal:  Biochem Pharmacol       Date:  1991-01-01       Impact factor: 5.858

6.  Effect of methionine replacement by homocysteine on the growth of cells.

Authors:  M J Tisdale
Journal:  Cell Biol Int Rep       Date:  1980-06

7.  A lipid mobilizing factor in serum of tumor-bearing mice.

Authors:  S Kitada; E F Hays; J F Mead
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

8.  Cachexia of malignancy: potential role of insulin in nutritional management.

Authors:  P S Schein; D Kisner; D Haller; M Blecher; M Hamosh
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

9.  An experimental model of cachexia induced by a xenografted human tumor.

Authors:  A J Strain; G C Easty; A M Neville
Journal:  J Natl Cancer Inst       Date:  1980-02       Impact factor: 13.506

10.  L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy.

Authors:  J R Uren; H Lazarus
Journal:  Cancer Treat Rep       Date:  1979-06
View more
  13 in total

1.  Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.

Authors:  Wei A He; Federica Calore; Priya Londhe; Alessandro Canella; Denis C Guttridge; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

Review 2.  Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.

Authors:  D Attaix; L Combaret; T Tilignac; D Taillandier
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

3.  Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats.

Authors:  L Combaret; C Rallière; D Taillandier; K Tanaka; D Attaix
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

4.  Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

Authors:  G Strassmann; M Fong; J S Kenney; C O Jacob
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 5.  MicroRNA in Cancer and Cachexia--A Mini-Review.

Authors:  Mario Acunzo; Carlo M Croce
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

6.  Regulation of glutathione metabolism in Ehrlich ascites tumour cells.

Authors:  J M Estrela; R Hernandez; P Terradez; M Asensi; I R Puertes; J Viña
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

7.  Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors.

Authors:  P C Dagnelie; J D Bell; S C Williams; T E Bates; P D Abel; C S Foster
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

8.  Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.

Authors:  G Strassmann; M Fong; C E Freter; S Windsor; F D'Alessandro; R P Nordan
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

Authors:  P Costelli; C García-Martínez; M Llovera; N Carbó; F J López-Soriano; N Agell; L Tessitore; F M Baccino; J M Argilés
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.

Authors:  P Terradez; M Asensi; M C Lasso de la Vega; I R Puertes; J Viña; J M Estrela
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.